Brevetti EPO No.3576740 2023.06.14
Brevetti EPO
(10) Registration Number and Date
2023000233 2023.08.01
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2023/000233 2018.02.02
(40) Publication Number and Date
SM /T/2023/000233 2023.08.01
(30) Priority Details
EP 17209098
2017.12.20
US 201762455211 P
2017.02.06
(71/73) Applicant
(72) Inventor
(IT) STUYCKENS, Kim : c/o Janssen Pharmaceutica NVTurnhoutseweg 30, 2340 Beerse, BE
(IT) DE PORRE, Peter, Marie, Z. : c/o Janssen Pharmaceutica NVTurnhoutseweg 30, 2340 Beerse, BE
(IT) AVADHANI, Anjali, Narayan : c/o Janssen Pharmaceuticals Inc.Springhouse Campus1400 McKean Road, SpringhousePennsylvania 19477, US
(IT) LORIOT, Yohann : c/o Gustave Roussy114, rue Édouard-Vaillant, 94805 Villejuif Cedex, FR
(IT) SIEFKER-RADTKE, Arlene, O. : c/o Janssen Pharmaceutica NVTurnhoutseweg 30, 2340 Beerse, BE
(IT) PEREZ RUIXO, Juan, Jose : c/o Janssen-Cilag, S.A.Edificio Johnson & JohnsonPaseo de las Doce Estrellas, 5-7, 5° plantaCampo de las Naciones, 28042 Madrid, ES
(74) Representative Name
(IT) SANTI, Filippo : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) TRATTAMENTO DI CANCRO
(EN) CANCER TREATMENT
(57) Abstract
(58) Citations